Search research articles
Contact Us
Filters
Showing results (761-770 of 779) with videos related to
Page
of 78
Sort By:
Journal for Immunotherapy of Cancer
|
June 19, 2026
Neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA-IIIB non-small cell lung cancer: integrated multidimensional biomarker analysis from a phase II study
Guoxin Cai, Pingping Song, Zhendan Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 21, 2020
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial
Ligang Xing, Gang Wu, Luhua Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 23, 2021
Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung Cancer
Li Li, Shanshan Tang, Jiani C Yin, et al.
International Journal of Hematology
|
May 4, 2013
IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations
H Dean Hosgood, Wing-Yan Au, Hee Nam Kim, et al.
Future Oncology (London, England)
|
May 5, 2025
Nanoray-312: phase III study of NBTXR3 + radiotherapy ± cetuximab in elderly, platinum-ineligible locally advanced HNSCC
Christophe Le Tourneau, Zoltán Takácsi-Nagy, Sandra Nuyts, et al.
Clinical and Translational Medicine
|
May 13, 2024
Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial
Xiaochu Man, Jie Huang, Shujuan Sun, et al.
JAMA Network Open
|
May 18, 2019
Association of Twice-Daily Radiotherapy With Subsequent Brain Metastases in Adults With Small Cell Lung Cancer
Haiyan Zeng, Rui Li, Chen Hu, et al.
Nature Cancer
|
May 13, 2026
Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trial
Solange Peters, Daniel S W Tan, David E Gerber, et al.
Targeted Oncology
|
May 3, 2026
Real-World Treatment Patterns and Clinical Outcomes Among Chinese Patients with Stage III NSCLC: The MOOREA Study
Ligang Xing, Jinming Yu, Xiangjiao Meng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2025
Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study
Minesh P Mehta, Vinai Gondi, Manmeet Singh Ahluwalia, et al.
Page
of 78
Search research articles
Search
Showing results (761-770 of 779) with videos related to
Sort By:
Page
of 78
Journal for Immunotherapy of Cancer
|
June 19, 2026
Neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA-IIIB non-small cell lung cancer: integrated multidimensional biomarker analysis from a phase II study
Guoxin Cai, Pingping Song, Zhendan Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 21, 2020
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial
Ligang Xing, Gang Wu, Luhua Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 23, 2021
Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung Cancer
Li Li, Shanshan Tang, Jiani C Yin, et al.
International Journal of Hematology
|
May 4, 2013
IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations
H Dean Hosgood, Wing-Yan Au, Hee Nam Kim, et al.
Future Oncology (London, England)
|
May 5, 2025
Nanoray-312: phase III study of NBTXR3 + radiotherapy ± cetuximab in elderly, platinum-ineligible locally advanced HNSCC
Christophe Le Tourneau, Zoltán Takácsi-Nagy, Sandra Nuyts, et al.
Clinical and Translational Medicine
|
May 13, 2024
Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial
Xiaochu Man, Jie Huang, Shujuan Sun, et al.
JAMA Network Open
|
May 18, 2019
Association of Twice-Daily Radiotherapy With Subsequent Brain Metastases in Adults With Small Cell Lung Cancer
Haiyan Zeng, Rui Li, Chen Hu, et al.
Nature Cancer
|
May 13, 2026
Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trial
Solange Peters, Daniel S W Tan, David E Gerber, et al.
Targeted Oncology
|
May 3, 2026
Real-World Treatment Patterns and Clinical Outcomes Among Chinese Patients with Stage III NSCLC: The MOOREA Study
Ligang Xing, Jinming Yu, Xiangjiao Meng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2025
Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study
Minesh P Mehta, Vinai Gondi, Manmeet Singh Ahluwalia, et al.
Page
of 78